Diosmin Tablets
Function and Efficacy
This product is a drug that enhances venous tension and a vascular protector. Pharmacology: The drug exerts its active effects on the venous vascular system in the following ways: reducing venous distensibility and venous blood congestion. In the microcirculatory system, it normalizes the permeability of the capillary wall and enhances its resistance. Clinical pharmacology In humans, a double-blind controlled study method was used to verify and quantitatively show the effect of the drug on venous hemodynamics. The results showed that it has the above-mentioned pharmacological properties.
Ingredients
Micronized, purified flavonoids 500 mg, including 450 mg of diosmin and 50 mg of flavonoids in the form of hesperidin.
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| DiosminIngredients |
Increases venous tone, reduces venous distensibility and venous blood congestion, normalizes the permeability of capillary walls and increases their resistance More |
520-27-4 | 16 |
Appearance
Oval, orange-yellow coated tablets.
Indication
Treats symptoms associated with venous lymphatic insufficiency (heaviness, pain, morning soreness and discomfort in the legs). Treats symptoms associated with acute hemorrhoidal attacks.
Usage and Dosage
Dosage: The usual dose is 2 tablets per day; when used for acute hemorrhoid attacks, 6 tablets per day for the first four days and 4 tablets per day for the next three days. Directions: Divide the daily dose into two equal doses and take them at lunch and dinner.
Adverse Reactions
There were a few reports of mild gastrointestinal reactions and autonomic nervous system disturbances, but none required discontinuation of treatment.
Precautions
none.
Special Population Medication
Precautions for children: Detailed research data is still lacking. Precautions for pregnancy and lactation: 1. Use in pregnant women: Animal experiments have not shown any teratogenic effects. Furthermore, no harmful effects have been reported to humans so far. 2. Childbirth: Detailed research data is still lacking. 3. Use in lactating women: Although there is no data on the secretion of drugs in breast milk, breastfeeding is not recommended during treatment. Precautions for the elderly: Elderly patients aged 70 years and above, or those with other concurrent diseases (such as hypertension, atherosclerosis, diabetes, neurological/psychiatric diseases, and alcoholism), have no significant difference in the incidence of adverse reactions, and no obvious interaction between diosmin and drugs used to treat these diseases has been observed.
Drug Interactions
So far, no interactions with other drugs have been found.
Storage
Store below 30°C.
Packaging Specification
Each tablet contains 0.45 g of diosmin
Validity Period
24 months
Manufacturer
Nanjing Chia Tai-tianqing Pharmaceutical Co., Ltd.
-
Founded in:
2001-08-31 -
Address:
No. 9 Huiou Road, Nanjing Economic and Technological Development Zone -
Tax NO.:
91320100730586189T -
Registered Funds:
336.031726 yuan -
Website:
-
Email: